| | Advances in the Detection of Rupture-Prone Plaque: The Role of Lipoprotein-Associated Phospholipase A2 in Cardiovascular Risk Assessment Guest Editor Michael H. Davidson, MD Clinical Professor of Medicine University of Chicago Pritzker School of Medicine Executive Medical Director Radiant Research Chicago, Illinois Faculty  Mark J. Alberts, MD Professor of Neurology Northwestern University Medical School Director, Stroke Program Northwestern Memorial Hospital Chicago, Illinois Jeffrey L. Anderson, MD Professor of Medicine, University of Utah Associate Chief of Cardiology, Cardiovascular Department LDS Hospital Salt Lake City, Utah Marshall A. Corson, MD Section Chief Cardiology, Harborview Medical Center Associate Professor of Medicine University of Washington Seattle, Washington Philip B. Gorelick, MD John S. Garvin Professor and Head Chief, Neurology Service Department of Neurology and Rehabilitation University of Illinois at Chicago College of Medicine Chicago, Illinois Peter H. Jones, MD Associate Professor and Co-Director Baylor Lipid and Atherosclerosis Clinic Baylor College of Medicine Houston, Texas Amir Lerman, MD Professor of Medicine Division of Cardiovascular Diseases Mayo Clinic College of Medicine Rochester, Minnesota Joseph P. McConnell, PhD Laboratory Director, Cardiovascular Laboratory Medicine Chair, Clinical Chemistry Fellowship Program Medical Director, Clinical Laboratory Sciences Program The Mayo Clinic and Foundation Rochester, Minnesota Howard Weintraub, MD Clinical Associate Professor Department of Medicine New York University Medical Center New York, New York PII: S0002-9149(08)00957-0 doi:10.1016/j.amjcard.2008.06.002 | |
|
|
FULL TEXT